Explore NMDAR2B/GRIN2B gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
This gene encodes a member of the N-methyl-D-aspartate (NMDA) receptor family within the ionotropic glutamate receptor superfamily. The encoded protein is a subunit of the NMDA receptor ion channel which acts as an agonist binding site for glutamate. The NMDA receptors mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation. Naturally occurring mutations within this gene are associated with neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy, and schizophrenia. [provided by RefSeq, Aug 2017]
| Target ID |
GM-T76414
|
| Target Name |
NMDAR2B/GRIN2B
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
2904
|
| Gene ID |
100063746 (Equus caballus), 101094356 (Felis catus), 14812 (Mus musculus), 24410 (Rattus norvegicus) 2904 (Homo sapiens), 494009 (Canis lupus familiaris), 537804 (Bos taurus), 698571 (Macaca mulatta)
|
| Target Alternative Names |
DEE27,EIEE27,GRIN2B,GluN2B,GluRepsilon2,Glutamate [NMDA] receptor subunit epsilon-2,Glutamate receptor ionotropic,Grin2b,MRD6,N-methyl D-aspartate receptor subtype 2B (NMDAR2B,N-methyl-D-aspartate receptor subunit 3 (NR3,NMDA 2B,NMDAR2B,NR2B,NR2B),NR3,Nmdar2b,hNR3,hNR3)
|
| Uniprot Accession |
Q01097,Q00960,Q13224,Q5R1P3
|
| Protein Sub-location |
Transmembrane Protein
|
| Category |
Therapeutics Target
|
| Disease from KEGG |
Ras signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Cocaine addiction, Amphetamine addiction, Nicotine addiction
|
| Gene Ensembl |
ENSECAG00000023247, ENSMUSG00000030209, ENSG00000273079, ENSCAFG00845022981, ENSBTAG00000000219, ENSMMUG00000019112
|
NMDAR2B/GRIN2B siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo2904 | Pre-made Human GRIN2B/NR3/MRD6 siRNA oligo Duplex | 2904 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo24410 | Pre-made Rat Grin2b/GluN2B siRNA oligo Duplex | 24410 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo14812 | Pre-made Mouse Grin2b/NR2B/GluN2B siRNA oligo Duplex | 14812 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo698571 | Pre-made Cynomolgus/Rhesus macaque GRIN2B siRNA oligo Duplex | 698571 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo101094356 | Pre-made Cat/Feline GRIN2B siRNA oligo Duplex | 101094356 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo494009 | Pre-made Dog/Canine GRIN2B/GluN2B siRNA oligo Duplex | 494009 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo537804 | Pre-made Bovines/Cattle GRIN2B siRNA oligo Duplex | 537804 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100063746 | Pre-made Equine/Horse GRIN2B siRNA oligo Duplex | 100063746 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
NMDAR2B/GRIN2B antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T76414-Ab | Human | Anti-Human NMDAR2B/GRIN2B monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-rg-T76414-Ab | Rat | Anti-Rat NMDAR2B/GRIN2B monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-mg-T76414-Ab | Mouse | Anti-Mouse NMDAR2B/GRIN2B monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T76414-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque NMDAR2B/GRIN2B monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-felg-T76414-Ab | Cat/Feline | Anti-Cat/Feline NMDAR2B/GRIN2B monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cang-T76414-Ab | Dog/Canine | Anti-Dog/Canine NMDAR2B/GRIN2B monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T76414-Ab | Bovines/Cattle | Anti-Bovines/Cattle NMDAR2B/GRIN2B monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-equg-T76414-Ab | Equine/Horse | Anti-Equine/Horse NMDAR2B/GRIN2B monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
NMDAR2B/GRIN2B VLP (virus-like particle)/protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T76414-Ag | Human | Human NMDAR2B/GRIN2B VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-rg-T76414-Ag | Rat | Rat NMDAR2B/GRIN2B VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-mg-T76414-Ag | Mouse | Mouse NMDAR2B/GRIN2B VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cynog-T76414-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque NMDAR2B/GRIN2B VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-felg-T76414-Ag | Cat/Feline | Cat/Feline NMDAR2B/GRIN2B VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cang-T76414-Ag | Dog/Canine | Dog/Canine NMDAR2B/GRIN2B VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-bovg-T76414-Ag | Bovines/Cattle | Bovines/Cattle NMDAR2B/GRIN2B VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-equg-T76414-Ag | Equine/Horse | Equine/Horse NMDAR2B/GRIN2B VLP (virus-like particle) | HEK293 | Products Developing |